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ABSTRACT
Lysosomes, as primary degradative organelles, are the endpoint of different converging pathways, 
including macroautophagy. To date, lysosome degradative function has been mainly studied in inter-
phase cells, while their role during mitosis remains controversial. Mitosis dictates the faithful transmis-
sion of genetic material among generations, and perturbations of mitotic division lead to chromosomal 
instability, a hallmark of cancer. Heretofore, correct mitotic progression relies on the orchestrated 
degradation of mitotic factors, which was mainly attributed to ubiquitin-triggered proteasome- 
dependent degradation. Here, we show that mitotic transition also relies on lysosome-dependent 
degradation, as impairment of lysosomes increases mitotic timing and leads to mitotic errors, thus 
promoting chromosomal instability. Furthermore, we identified several putative lysosomal targets in 
mitotic cells. Among them, WAPL, a cohesin regulatory protein, emerged as a novel SQSTM1-interacting 
protein for targeted lysosomal degradation. Finally, we characterized an atypical nuclear phenotype, the 
toroidal nucleus, as a novel biomarker for genotoxic screenings. Our results establish lysosome- 
dependent degradation as an essential event to prevent chromosomal instability.
Abbreviations: 3D: three-dimensional; APC/C: anaphase-promoting complex; ARL8B: ADP ribosylation 
factor like GTPase 8B; ATG: autophagy-related; BORC: BLOC-one-related complex; CDK: cyclin-dependent 
kinase; CENPE: centromere protein E; CIN: chromosomal instability; ConcA: concanamycin A; CQ: chlor-
oquine; DAPI: 4,6-diamidino-2-penylinole; FTI: farnesyltransferase inhibitors; GFP: green fluorescent 
protein; H2B: histone 2B; KIF: kinesin family member; LAMP2: lysosomal associated membrane protein 
2; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MEF: mouse embryonic fibroblast; 
MTOR: mechanistic target of rapamycin kinase; PDS5B: PDS5 cohesin associated factor B; SAC: spindle 
assembly checkpoint; PLEKHM2: pleckstrin homology and RUN domain containing M2; SQSTM1: seques-
tosome 1; TEM: transmission electron microscopy; ULK1: unc-51 like autophagy activating kinase 1; UPS: 
ubiquitin-proteasome system; v-ATPase: vacuolar-type H+-translocating ATPase; WAPL: WAPL cohesion 
release factor.
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Introduction
Chromosomal instability (CIN) is defined as an abnormal 
gain or loss of chromosomes during cell division [1] and 
positively correlates with poor cancer patient prognosis [2]. 
The mechanisms underlying CIN remain poorly character-
ized but reflect abnormalities in kinetochore-microtubule 
attachment, sister chromatids cohesion, centrosome duplica-
tion, telomeres or the spindle assembly checkpoint 
(SAC) [3].
To maintain genome integrity, the cell cycle must be tightly 
coordinated to ensure the faithful transmission of hereditary 
information between generations. Cells spend more than 90% 
of their time in interphase, and interphase length correlates 
with total length of the cell cycle [4]. In contrast, mitosis time 
is extremely short, remarkably constant and uncoupled from 
the variability in other phases. Mitosis is the process by which 
a cell properly divides its genetic material and consists of five 
active phases from prophase to telophase. The major mitotic 
checkpoint known as SAC comprises the metaphase-to- 
anaphase transition, separating mitotic entry and exit. 
Coordination of the mitotic regulatory network relies on 
hierarchal phosphorylation cascades driven by cyclin- 
dependent kinases (CDKs) [5,6] and the ubiquitin- 
proteasome system (UPS) under the control of the anaphase- 
promoting complex (APC/C) [7,8]. During mitosis, known 
degradative functions are mainly restricted to UPS, specialized 
in ubiquitin-triggered protein degradation and presumably 
faster than lysosome-dependent degradation.
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Lysosomes are acidic cytosolic vesicles responsible to enzy-
matically degrade all types of biological material. During 
macroautophagy/autophagy, double-membrane vesicles 
(autophagosomes) engulf cytosolic material, converge and 
fuse with lysosomes. The lysosomal proton pump vacuolar- 
type H+-translocating ATPase (v-ATPase) drives lumen acid-
ification while the BLOC-one-related complex (BORC)- 
associated proteins, including KIF5B motor protein, is the 
main driver of anterograde lysosomal transport and also con-
tributes to autophagosome-lysosome fusion [9–11]. 
Autophagy-dependent degradation of cargos can either be 
nonselective (bulk) or targeted (selective). Receptor proteins, 
such as SQSTM1/p62 (sequestosome 1), regulate selective 
autophagy [12,13]. Being cytosolic vesicles, research on autop-
hagy and lysosomes has mainly focused on interphase cells. 
As cells undergo mitosis, dramatic structural rearrangements 
of organelles occur [14–16]. Recent studies present controver-
sial observations about the function of lysosomes and autop-
hagy in mitosis. Some of them claim that autophagy signaling 
is shut-down at mitotic entry, that autophagic structures are 
barely detected in dividing cells and that proteasome- 
dependent WIPI2 degradation upon mitotic induction sup-
presses autophagic flux [17–20]. In contrast, lysosomal- 
dependent degradation has been implicated in CCNA2 (cyclin 
A2) proteolysis during mitosis [21] and mitophagy has been 
shown to remain active in prophase [22,23]. ULK1 (unc-51 
like autophagy activating kinase 1), an autophagy initiator 
protein, was shown to drive SAC recruitment to kinetochores 
through MAD1 L1 (mitotic arrest deficient 1 like 1) phos-
phorylation [24]. Furthermore, selective autophagic degrada-
tion of centriolar satellites was recently demonstrated to 
support correct karyokinesis [25,26]. Loss of BECN1 
(beclin 1), another key autophagic protein, induced gene 
amplification and consequent aneuploidy [27]. Better under-
standing of the regulatory mechanisms driving mitotic transi-
tions is crucial to prevent CIN and develop novel cancer 
treatment strategies.
Here, we show that correct mitotic progression does not 
rely only on UPS-dependent degradation. Dissecting the 
mitotic progression, we define a novel function of selective 
autophagy and lysosome-dependent degradation specifically 
in dividing cells and identify new mitotic lysosomal sub-
strates. Furthermore, impairment of lysosome function during 
cell division triggers chromosome mis-segregation and 
induces a striking nuclear phenotype in progeny, the toroidal 
nucleus, which provides a new tool for genotoxicity tests.
Results
Lysosomes and autophagic vesicles are present and 
active during cell division
To investigate the presence of lysosomes in mitotic sub-
phases, LAMP2-positive vesicles and DAPI-stained DNA 
were analyzed by immunofluorescence. Here, we showed 
that lysosomes are present and dynamic in all mitotic sub-
phases (Figure 1A and Video 1). Morphological analysis of 
mitotic lysosomes indicated that lysosomes decreased in 
number while increased in size from prophase to telophase, 
when they started recovering their interphase-like morphol-
ogy (Figure 1A–C and Video 1). In addition, lysosome 
distribution changed once cells proceeded into cell division. 
Mitotic lysosomes surrounded the chromosomes in pro-
phase and moved to the edges of chromosomes during 
anaphase/telophase until chromosomes decondensed 
(Figure 1D). To analyze whether mitotic lysosomes main-
tain their degradation capacity during cell division, we 
stained live U2OS cells stably expressing Histone 2B-GFP 
(H2B-GFP U2OS) with LysoSensor for acidic organelle 
detection and Magic Red for lysosomal CTSB (cathepsin 
B) activation. Colocalization between LysoSensor and Magic 
Red supported the presence of functional lysosomes in 
dividing cells (Figure 1E and S1A).
As we found that lysosomes are present and active in 
mitosis, we analyzed the autophagic flux during cell division. 
To this end, we detected and quantified acidified and non- 
acidified autophagic vesicles using MAP1LC3/LC3-tandem 
(RFP-GFP-LC3) reporter in mitotic cells treated or not with 
concanamycin A (ConcA) or chloroquine (CQ) (Figure 1F, 
1G and S1B). The presence of acidified autophagic vesicles 
(red-only vesicles) in control conditions confirmed that lyso-
some acidification takes place while cells progress through 
mitosis. Inhibition of autophagic flux by ConcA or CQ was 
supported by the significant increase of non-acidified autop-
hagic vesicles throughout the mitotic subphases (Figure 1F, 
1G and S1B). Next, we analyzed the expression of SQSTM1 
and the lipidated form of LC3 (LC3-II) in mitosis after 
inhibition of lysosomal acidification with ConcA. 
Established synchronization protocols, such as serum starva-
tion or double-thymidine block, were insufficient to effi-
ciently synchronize U2OS cells in G2. Therefore, based on 
the ability of CDK1-specific inhibitor RO3306 to reversibly 
block cells in G2, we established a synchronization-release 
protocol to obtain enriched mitotic population (Fig. S1C). 
After synchronization, cells released with ConcA treatment 
for 8 h showed specific accumulation of LC3-II and SQSTM1 
(Figure 1H and S1D). Time-course assay after cell synchro-
nization and release demonstrated that both autophagic pro-
teins gradually accumulated during mitosis transition upon 
acidification blockade (Fig. S1E and S1F). Subsequently, the 
upstream regulator of autophagy initiation, mechanistic tar-
get of rapamycin kinase complex 1 (MTORC1), was analyzed 
(Fig. S1G-J). Interestingly, MTORC1 activity, measured by 
the phosphorylation of RPS6KB1 and RPS6, increased in 
control cells at G1 reentrance while cells treated with 
ConcA displayed lower MTORC1 activity (Fig. S1G). 
Furthermore, analysis of MTORC1 status in mitotic cells 
compared to interphase cells, demonstrated that MTORC1 
activity decreased, independently of ConcA treatment (Fig. 
S1H). Complementary immunofluorescence analysis showed 
a decreased recruitment of MTOR to the lysosomes upon 
mitotic entry, which was slowly recovered after cells entered 
mitotic exit (Fig. S1I and S1J). Together, our results sug-
gested that MTORC1 lysosomal translocation also correlates 
with its activity during mitosis.
The presence of autophagic vesicles in dividing cells was 
corroborated by immunofluorescence analysis of both endo-
genous LC3 and SQSTM1 (Fig. S1K). Indeed, the number and 
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the size of LC3-positive vesicles was significantly increased 
upon CQ treatment in interphase as well as in mitotic entry 
and mitotic exit, confirming an active autophagic flux in 
mitosis (Fig. S1K and S1L). Finally, double-membrane vesicles 
(autophagosomes), as well as dense single-membrane vesicles 
(autolysosomes/lysosomes), were detected by transmission 
electron microscopy (TEM) in mitotic cells (Figure 1I). 
Collectively, our results demonstrated that both autophagic 
vesicles and functional lysosomes are present and active in 
mitotic cells.
Figure 1. Autophagic flux and lysosome-dependent degradation are active in dividing cells. (A) Representative single focal plane (1Z) confocal images of U2OS cells 
undergoing mitosis labeled with lysosomal marker LAMP2 (green). Interphase cell and distinct mitotic subphases are detectable with DNA staining with DAPI (blue). 
Scale bar: 10 µm. (B-C) Quantification of lysosome number (B) and size (C) per cell in interphase compared to each mitotic subphase. Error bars represent S.D. of 
n ≥ 10 cells. (D) Upper panel: Analysis of the distribution of lysosomes (green) and DNA (blue) in interphase and for each mitotic subphase using Radial Profile Angle 
ImageJ plugin. A radius of 20 μm was maintained constant for the analysis. Lower panel: representative image of a cell in each analyzed phase. (E) Representative 
single focal plane confocal images of U2OS H2B-GFP stable cells in interphase or undergoing mitosis were stained with LysoSensor (green – arbitrary color) for 
lysosomes detection, Magic Red (red) for active CTSB, H2B-GFP (blue – arbitrary color) for DNA staining. Scale bar: 10 µm. (F) Representative single focal plane (1Z) 
confocal images of U2OS LC3-Tandem cells in interphase or undergoing mitosis. Presence of yellow and red vesicles indicates autophagosomes and autolysosomes, 
respectively. Nuclei were stained with DAPI for DNA detection. Scale bar: 10 µm. (G) U2OS cells stably expressing LC3-tandem construct were treated or not with 
ConcA (10 nM) or CQ (10 µM) for 24 h. Quantification of red (acidified) and yellow (non-acidified) autophagic vesicles in interphase and mitotic cells under the 
indicated conditions was performed. (H) Analysis of autophagic flux by western blot detection upon synchronization-release protocol (T0: G2 population; T8: G1 
population after mitosis). Autophagic proteins SQSTM1 and LC3 were analyzed and ACTB/β-actin protein level was used as loading control. (I) Representative TEM 
images of mitotic cells. Green asterisks indicate autophagic vesicles, blue asterisks mark lysosomes and yellow asterisks point out mitochondria. Scale bars: as 
indicated. Panels B, C, and G, statistical significance between interphase and mitotic subphases is represented as: * p < 0.05, ** p < 0.005, *** p < 0.001, ns: non- 
significant.
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Lysosome acidification capacity and trafficking maintain 
correct mitotic progression
To investigate the role of lysosomes in cell division, we stu-
died mitotic cells with impaired lysosomes either by inhibiting 
their degradative capacity or their intracellular trafficking. 
Impairment of lysosome acidification by the v-ATPase inhi-
bitor ConcA led to an increase in mitotic lysosome size, 
according to a defective degradation capacity, without signifi-
cantly affecting their number or LAMP2 protein levels (Figure 
2A, 2D, 2E and S2A). Next, we assessed the effect of the 
BORC-associated motor protein KIF5B depletion on lysosome 
morphology, number and distribution in mitotic cells (Figure 
2B–E, S2B and S2C). In both interphase and mitotic cells, 
KIF5B depletion induced a reduction in the lysosomal num-
ber without dramatically affecting their size (Figure 2B–D). 
The distribution of lysosomes was strongly affected in cells 
depleted for KIF5B in interphase (Figure 2D, 2E), as pre-
viously reported [11,28]. Moreover, analysis of the distribu-
tion of lysosomes in the different mitotic subphases showed 
a change in the localization of lysosomes induced by KIF5B 
depletion (Figure 2E). Indeed, KIF5B-depleted cells lysosomes 
were closer to the DNA in metaphase cells compared to 
control cells, as shown by an increase in proximal lysosomes 
and a decrease in distant lysosomes (Figure 2E, S2D and S2E). 
In anaphase, an accumulation of lysosomes between the seg-
regated chromosomes occurred upon KIF5B depletion, shown 
by an increase in proximal lysosomes versus distant lysosomes 
(Figure 2E, S2D and S2E). These results suggest the implica-
tion of this kinesin on the appropriate distribution of lyso-
somes during mitosis.
Mitotic timing is strictly regulated and remarkably con-
stant among different cell types and species [4], taking 
approximately 1 h in normal mitosis. Thus, after identifying 
active lysosomes in dividing cells, the direct implication of 
lysosomes in mitotic progression was tested. To this end, we 
used live-imaging to analyze H2B-GFP U2OS cells treated or 
not with ConcA or KIF5B-depleted and analyzed the mitotic 
timing from prophase (chromosome condensation) to telo-
phase (chromosome decondensation). Mitosis was 22% slower 
in ConcA-treated cells compared to control, and KIF5B deple-
tion delayed mitotic progression to the same extent (Figure 
2F, 2G and Videos 2–4). Combination of ConcA-treatment 
with KIF5B knockdown increased the average mitotic dura-
tion by 45% versus control (Figure 2F and 2G). In all, integ-
rity of both lysosome transport and functionality is key for 
preserving mitotic schedule. To precisely characterize the 
involvement of lysosomes in mitotic progression, we sepa-
rately analyzed the timing of mitotic entry (prophase to meta-
phase) and exit (metaphase to telophase). Interestingly, both 
episodes were delayed by treatments that impaired lysosomes. 
Consistently, the additive effect was reflected in both mitotic 
entry and exit (Fig. S2F).
One of the main causes of mitotic delay is the accumula-
tion of mitotic errors such as misaligned chromosomes at 
metaphase plate or chromosome bridges appearing during 
chromosome segregation in anaphase [29] (Figure 2H). 
Thus, we next quantified the acquirement of mitotic errors 
in synchronized cells released with or without ConcA. Our 
results demonstrated that lysosome acidification blockade sig-
nificantly induces the accumulation of misaligned chromo-
somes and chromosome bridges (Figure 2I, 2J). In parallel, we 
tested whether, beyond acidification, the protective role of 
lysosomes against mitotic errors also relies on trafficking. 
Depletion of the motor protein KIF5B significantly induced 
mitotic errors (Figure 2K, 2L). To corroborate that this effect 
was specific of lysosomal trafficking, other BORC-associated 
proteins were tested. To this end, ARL8B (ADP ribosylation 
factor like GTPase 8B) and PLEKHM2 (pleckstrin homology 
and RUN domain containing M2) were depleted, and mitotic 
errors were analyzed. Consistent with a role of lysosomal 
trafficking in mitosis progression, both chromosome misa-
lignment and chromosomal bridge were increased upon 
ARL8B and PLEKHM2 depletion (Fig. S2G-I). Thus, active 
lysosomes are important organelles to ensure correct mitosis 
progression and limit CIN signature.
Mitotic errors induced by lysosome impairment correlate 
with an abnormal nuclear phenotype: the toroidal 
nucleus
Defective mitotic progression generated a robust and striking 
nuclear phenotype in interphase cells. Precisely, we observed 
a DAPI-stained nucleus with a hole devoid of chromatin 
(Figure 3A). To understand how this structure was originated, 
we followed the DNA reorganization during mitosis by live- 
imaging using H2B-GFP U2OS cells. Our results showed that 
this unconventional nuclear phenotype forms upon mitosis, 
being detectable in at least one of the daughter cells once 
chromosomes decondensed (Figure 3B and Video 5). To 
assure that this structure does not correspond to an enlarged 
nucleolus [30], immunofluorescence analysis was performed 
and results showed that none of the tested nucleolar markers 
(NCL [nucleolin], FBL [fibrillarin] and UBTF [upstream 
binding transcription factor]) co-stained with the DAPI-free 
area (Figure 3C and S3A). To resolve whether this section is 
nuclear or cytosolic, we imaged the nuclear envelope by 
immunofluorescence using LMNB1 (lamin B1) and nuclear 
pore complex (NPC) antibodies (Figure 3D and S3B). 
Interestingly, the nuclear envelope was correctly formed 
around the DNA. Further immunofluorescence analysis 
showed that cytoskeleton filaments such as Phalloidin- 
stained actin fibers and microtubules, as well as LAMP2- 
positive lysosomes or LC3-SQSTM1-positive autophago-
somes, were present within the void at the center of the nuclei 
(Figure 3E, S3C and S3D). To discard a nuclear invagination 
and/or an artifact, three-dimensional (3D) reconstruction of 
high-quality images using IMARIS software resulted in the 
characterization of a donut-like shaped structure that we refer 
to as a “toroidal nucleus” (Figure 3F and Video 6). 
Ultrastructure analysis of these toroidal nuclei by TEM con-
firmed that cytosolic material, including autophagic vesicles 
and lysosomes, were present within the hole (Figure 3G).
This phenotype was once reported as donut-shaped 
nucleus [31]. The authors proposed that farnesyltransferase 
inhibitors (FTI) induce the formation of toroidal nuclei by 
causing a PCNT (pericentrin)-related centrosome separation 
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defect in HeLa cells. Thus, we tested whether FTI induced the 
formation of toroidal nuclei in our model. After confirming 
the increase of toroidal nuclei by FTI in HeLa cells (Fig. S3E, 
left), we demonstrated that U2OS cells did not respond to FTI 
(Fig. S3E, right). This contrasts with our results that impair-
ment of lysosome acidification by ConcA, which significantly 
increased the percentage of toroidal nuclei in both cell types 
(Fig. S3E). To verify that FTI does not stimulate toroidal 
nuclei formation with different kinetics in U2OS, we analyzed 
U2OS cells treated for 24 h, 48 h and 72 h with FTI or ConcA. 
While ConcA gradually induced a robust increase of toroidal 
nuclei with time, FTI did not (Fig. S3F).
Next, we analyzed whether inhibition of lysosome acidifi-
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Figure 2. Lysosome impairment delays mitotic progression and leads to chromosomal instability. (A-B) U2OS cells were treated with ConcA 10 nM for 24 h (A) or 
transiently transfected with silencing RNA against KIF5B (siKIF5B) (B). Single plane confocal images show LAMP2-positive lysosomes (green) detected by immuno-
fluorescence in cells undergoing mitosis. DNA is labeled with DAPI (blue). Scale bars: 10 µm. (C-D) Comparison of the number of lysosomes per cell (C) or average 
lysosome size (D) in interphase and each mitotic subphases in control, ConcA-treated or KIF5B-depleted cells. Line represents the mean and error bars correspond to 
5–95 percentiles. n ≥ 10 images per condition. (E) Intracellular distribution of lysosomes (proximal and distant) in interphase and in each mitotic subphases in control 
and KIF5B-depleted cells. n ≥ 10 images per condition. (F) H2B-GFP U2OS cells were subjected to time-lapse imaging for 24 h every 6 min 33 s. Single focal plane of 
representative images of control cells, cells treated with ConcA 10 nM or depleted for KIF5B (siKIF5B) for 48 h undergoing mitosis are shown. H2B-GFP is depicted in 
grayscale (arbitrary color). Scale bars: 5 µm. (G) Quantification of mitotic timing of the indicated experimental conditions was performed from prophase 
(chromosomes condensation) to telophase (chromosomes decondensation). Error bars represent 5–95 percentiles of n ≥ 90 mitosis. (H) Representative images of 
misaligned metaphase plate and chromosome bridges. Scale bar: 5 µm. (I-J) U2OS cells were synchronized at late G2 phase and released with or without ConcA for 
1 h to analyze chromosome misalignment compared to total metaphase (I) or 3 h for chromosomal bridges quantification compared to total anaphases (J). DAPI 
staining was used for DNA detection. Error bars represent S.D. of n = 3 independent experiments (> 200 cells). (K-L) U2OS cells depleted for KIF5B (siKIF5B) or 
transfected with siRNA control (siNT) were synchronized and released for 1 h to determine the percentage of chromosome misalignment (K) or 3 h for chromosome 
bridges (L) relative to the total number of cells undergoing metaphase or anaphase, respectively. Error bars represent S.D. of n = 3 experiments (> 150 cells). In 
panels C-E, G and I-L, statistical significance is represented as: * p < 0.05, ** p < 0.005, *** p < 0.001, ns: non-significant.
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farnesylation of LMNA (lamin A/C). Neither ConcA nor CQ 
impeded LMNA farnesylation like FTI (Fig. S3G). Based on 
these results, we hypothesized that the formation of toroidal 
nuclei is not due to the inhibition of farnesylation per se, but 
to a defect in mitotic progression regardless of its inducer. As 
toroidal nuclei were formed following karyokinesis, we exam-
ined by live imaging a putative link between the occurrence of 
mitotic errors and the formation of toroidal nuclei. The 
results showed a linear correlation between detectable mitotic 
errors and toroidal nucleus generation with a Pearson’s cor-
relation coefficient of 0.806 (Figure 3H). Indeed, single-cell 
analysis demonstrated that more than 80% of cells with tor-
oidal nuclei resulted from cells undergoing apparent defective 
mitosis (Figure 3I). Based on this, we next investigated the 
repercussion of mitotic stresses on generating toroidal nuclei. 
To this end, we depleted cells of KIF11, a kinesin required for 
bipolar spindle establishment [32], and analyzed the forma-
tion of toroidal nuclei. Disruption of KIF11 by small interfer-
ing RNA (siKIF11) or by the KIF11-specific inhibitor 
monastrol induced a significant increase in toroidal nucleus 
frequency (Figure 3J and 3K) without dramatically affecting 
lysosome morphology and localization (Fig. S3H).
Depletion of other kinesins implicated in chromosome 
segregation, such as siKIF2C/MCAK (kinesin family member 
2 C) [33] or siCENPE (centromere protein E) [34] produced 
a 3.3- and 3.8-fold increase of toroidal nucleus population, 
respectively (Fig. S3I). In all conditions, siRNA efficiency was 
validated, and lysosomes morphology or distribution were not 
apparently perturbed (Fig. S3J and S3K). Furthermore, cells 
treated with nocodazole, a microtubule de-polymerizing 
agent, showed a 4.5-fold increased prevalence of toroidal 
nuclei accompanied by the expected lysosomal collapse (Fig. 
S3I and S3K). We next investigated whether this phenotype is 
a consequence of impaired nuclear envelope reformation. Live 
imaging of H2B-GFP U2OS cells stably expressing mCherry- 
LMNA, indicated that the reformation of the nuclear envelope 
preceded the formation of toroidal nuclei (Fig. S3L and 
Video 7). This nuclear phenotype is versatile in terms of 
size, nuclear localization and morphology (Fig. S3M i-iv). 
Furthermore, the nucleus could contain more than one void 
(Fig. S3M v, viii) and be accompanied by a micronucleus (Fig. 
S3M vi). After mitosis, one or both daughter cells could 
harbor this phenotype (Fig. S3M vii-viii).
We investigated whether toroidal nucleus was a common 
feature or specific to U2OS cells. To this end, we screened 
a panel of cell lines. Toroidal nuclei were detected under the 
tested conditions in more than 80% of cell lines assessed 
(Figure 3L). Among them, non-transformed human skin 
fibroblast (HFF) and embryonic mouse fibroblasts (MEF), as 
well as cancer cells from lung (A549), cervix (HeLa), colon 
carcinoma (HCT116 and LoVo) or diffuse intrinsic pontine 
glioma (SU-DIPG-XVII, MC-PED17 and SF-8628) [35–38]. 
However, we could not detect toroidal nucleus in RKO, MCF7 
or HEK293 T cell lines neither in basal population nor under 
ConcA or monastrol treatment. Interestingly, the detection of 
toroidal nuclei in all the other cell lines was evident (compare 
Figure 3M and S3N), but their sensitivity to induce this 
nuclear phenotype under the applied treatments varied 
(Figure 3L). Importantly, most cell lines responded to ConcA- 
induced blockade of lysosome acidification and to direct 
mitotic impairment by monastrol as observed by the increased 
population of toroidal nuclei (Figure 3L and 3M). Thus, 
toroidal nuclei emerge as a good read-out for mitotic errors 
in interphase cells.
Lysosome disruption induces the formation of toroidal 
nuclei
The presence of toroidal nuclei in interphase cells facilitates 
the analysis of mitotic impairment in whole-cell populations, 
favoring the toroidal nucleus as a powerful tool for quantita-
tive analysis of chromosomal instability. Here, we aimed to 
screen for lysosome-specific stresses using toroidal nucleus as 
a biomarker for chromosomal instability. To this end, cells 
were treated with ConcA or depleted for KIF5B and toroidal 
nuclei frequency was quantified. Consistently, v-ATPase inhi-
bition as well as blockage of lysosome transport led to 
a robust increase of toroidal nuclei population (Figure 4A 
and S4A). To discard ConcA-side effects not related to 
v-ATPase inhibition, we genetically or chemically inhibited 
lysosome acidification. Thus, cells were treated with CQ or 
depleted of the V0C v-ATPase subunit (siATP6V0C). In 
agreement, inhibition of lysosome acidification increased the 
formation of toroidal nucleus by 2.5- to 3-fold (Figure 4B and 
S4B). To validate treatment efficiency, both blockade of the 
autophagic flux and morphological analysis of lysosomes were 
assessed by western blot or immunofluorescence, respectively. 
Our results confirmed the expected accumulation of LC3-II 
protein levels and increase in lysosomal volume [39] (Figure 
4C, 4D and S4A, S4B, respectively).
Both ConcA and CQ increased toroidal nucleus formation, 
but their kinetics differed (Fig. S4C). Indeed, ConcA treat-
ment acted faster and produced a peak effect at 24 h, while 
CQ produced a similar effect after 48 h, and further increased 
at 72 h (Fig. S4C). We further asked whether defects in 
BORC-dependent lysosome trafficking would also induce the 
formation of toroidal nuclei. Cells genetically depleted of 
BORC-associated proteins ARL8B or PLEKHM2 also showed 
a significant increase in the population of toroidal nuclei (2.3- 
and 4.1-fold, respectively) confirming the importance of lyso-
somal trafficking for correct mitotic progression (Figure 4E). 
Depletion efficacy was corroborated by the perinuclear clus-
tering of lysosomes (Fig. S4D) as well as by significant 
decrease of protein or mRNA levels (Fig. S2I). Additionally, 
we examined the specificity of the motor function of KIF5B in 
the formation of toroidal nucleus by complementing control 
or KIF5B-depleted cells with the neuronal form KIF5A, which 
resulted in a rescue of normal toroidal nucleus frequency 
(Figure 4F). Interestingly, depletion of other motor proteins 
involved in lysosomal trafficking such as KIF3A, KIF2A or 
KIF1A also led to a significant increase in toroidal nuclei (Fig. 
S4E-G). Parallel to the delay in mitotic timing, we found that 
simultaneous disruption of lysosome acidification (ConcA) 
and trafficking (siKIF5B or siPLEKHM2) had an additive 
effect on toroidal nucleus formation compared to single treat-
ments (Figure 4G). In all, our results confirm that both 
v-ATPase-dependent lysosome acidification and BORC- 
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associated lysosomal trafficking are required to preserve mito-
tic integrity.
Impairment of lysosome functionality does not appear to 
prevent mitotic cells from progressing into G1 phase but leads 
to CIN. In cells synchronized and released specifically in 
mitosis, ConcA and CQ similarly led to toroidal nuclei for-
mation (2.6- and 2.7-fold increase, respectively) (Fig. S4H and 
S4I), indicating that the different kinetics of toroidal nucleus 
formation might be due to the effect of the drugs in other 
phases of the cell cycle. Interestingly, neither MG132 nor 
monastrol induced toroidal nuclei in these conditions (Fig. 
S4H and S4I), but rather imped cells from properly conclud-
ing cell division as previously demonstrated [40,41], thus 
limiting the generation of subsequent daughter cells harboring 
toroidal nuclei (Fig. S4I). We confirmed that inhibition of 
proteasome-dependent degradation by MG132 arrests cells at 
G2, as showed by a significant decrease of the mitotic index as 
well as an increase in G2/M phase by flow cytometry analysis 
Figure 3. Toroidal nucleus is a novel biomarker for chromosomal instability in interphase cells. (A) Representative image of toroidal nucleus. U2OS cells were fixed 
and stained with DAPI for DNA detection. Scale bar: 5 µm. (B) Live imaging of H2B-GFP U2OS cells undergoing cell cycle for 16 h every 93 s. Mosaic of single focal 
plane images indicate aberrant nucleus formation upon cell division. Scale bar: 10 µm. (C-E) U2OS cells were fixed and immunofluorescence was performed using 
NCL (nucleolin) antibody for nucleolus detection (C), LMNB1 (lamin B1) antibody for nuclear envelope staining (D) or LAMP2 antibody to mark lysosomes (E) and 
DAPI for DNA labeling. Scale bar: 5 µm. (F) 3D reconstruction using IMARIS software was performed from confocal images stack of toroidal nucleus (Z every 0.1 µm 
for 11 µm). Blue corresponds to DAPI-stained nucleus and yellow dots mark LAMP2-positive lysosomes. (G) U2OS cells were treated with ConcA for 24 h, fixed and 
prepared for TEM. Images show toroidal nucleus surrounded by the nuclear envelope. Abbreviations: NE: nuclear envelope, N: nucleus, Cyt: cytosol, AV: autophagic 
vesicles. Scale bars: as indicated. (H) Analysis of live imaging experiment of cycling H2B-GFP U2OS cells for 24 h every 9 min. The number of mitotic cells with 
detectable mitotic errors (misaligned chromosomes or chromosomal bridges) and toroidal nuclei per field were quantified. Linear regression was analyzed and 
Pearson’s coefficient (R) was calculated. (I) Analysis of the percentage of toroidal nucleus formed upon non-apparent mitotic error or after mitotic errors. Error bars 
represent S.D. of n = 295 mitosis. (J) U2OS cells were depleted for KIF11 for 48 h using silencing RNA or treated with monastrol 100 µM for 24 h. Quantification of 
toroidal nuclei was performed by detection of DAPI-stained nuclei. Error bars represent S.D. of n > 3 experiments (10 fields/experiment). (K) Samples from panel 
J were processed by western blot and KIF11 protein levels were analyzed for knockdown efficiency. ACTB was used as a loading control. (L) Table summarizing 
a screen for toroidal nuclei through various cell lines. Percentage of toroidal nuclei was analyzed in basal population and upon ConcA or monastrol treatments. (M) 
Representative images of toroidal nuclei in screened cell lines from panel K. Scale bar: 5 µm. Panels I and J statistical significance is represented as: * p < 0.05, ** 
p < 0.005, *** p < 0.001, ns: non-significant.
AUTOPHAGY 7
(Fig. S4J and S4K). These results further suggest that lyso-
somes are not required to complete mitosis, but chromosomal 
instability is triggered when lysosomes are impaired.
Autophagy is a key player in maintaining mitosis fidelity
As we have detected the presence of autophagic vesicles in 
mitosis and being that lysosomes are the endpoint of autop-
hagy, we analyzed the involvement of macroautophagy for 
faithful mitotic progression by scoring for toroidal nucleus 
frequency after macroautophagy inhibition. Genetic depletion 
of ATG5 (siATG5) induced a 5.11-fold increase in the propor-
tion of toroidal nuclei (1.6-fold increase) (Figure 5A), while 
ConcA did not significantly affect the formation of toroidal 
nucleus in this setting (Figure 5A). In agreement with the 
correlation between mitotic errors occurrence and formation 
of toroidal nuclei, the inhibition of autophagy by ATG5 
depletion provoked a significant increase in misaligned chro-
mosomes and chromosome bridges (Figure 5B and 5C). 
Protein depletion efficiency was monitored by western blot 
(Fig. S5A). Chemical inhibition of autophagy by 3-methyla-
denine (3-MA), a PtdIns3 K inhibitor, also resulted in an 
increase in toroidal nuclei frequency together with an 
enhanced detection of chromosomal misalignment (Fig. S5B 
and S5C). As U2OS is a cancer cell line already susceptible to 
genomic instability and chromosome alterations [42], we used 
MEF to analyze the impact of defective autophagy on mitotic 
progression in a non-tumoral model. First, we validated 
ConcA efficiency and autophagic flux impairment by analyz-
ing ATG5 and LC3 protein levels (Figure 5D). Then, we 
quantified the frequency of toroidal nuclei in WT (atg5+/+) 
and atg5 KO (atg5-/-) MEF. As expected, ConcA treatment 
significantly increased toroidal nuclei cell population in MEF 
WT (Fig. 5E, 5F, 3L and 3M). Parallel to the depletion of 
ATG5 in U2OS cells, MEF atg5-/- presented a significantly 
increased percentage of toroidal nuclei under normal growing 
conditions, supporting that basal autophagy prevents CIN. 
MEF atg5-/- were significantly more susceptible to chromoso-
mal misalignment and chromosomal bridges compared to 
MEF WT (2.36- and 1.48-fold increase, respectively) (Figure 
5G and 5H). Inhibition of v-ATPase-dependent lysosomal 
acidification by ConcA clearly increased chromosome misa-
lignment and chromosomal bridges in control MEF WT 
(Figure 5G and 5H). Interestingly, cells lacking ATG5 showed 
a milder response to inhibition of lysosomal acidification 
regarding both mitotic errors and toroidal nucleus formation 
(Figure 5E, 5G and 5H), suggesting that macroautophagy is 
the main responsible process for those phenotypes, although 
macroautophagy-independent lysosome degradation could 
also occur, as suggested by the residual effects of ConcA in 
MEF atg5-/-. Altogether, our results establish the involvement 




Figure 4. Toroidal nucleus frequency increases upon impairment of lysosome trafficking and acidification capacity. (A) U2OS cells were treated with ConcA (10 nM) 
for 24 h or depleted for KIF5B for 48 h using silencing RNA. Error bars represent S.D. of n > 5 experiments. (B) U2OS cells were treated with CQ (10 µM) or depleted 
for the V0C subunit of the v-ATPase (siATP6V0C) for 48 h. Error bars represent S.D. of n > 3 experiments. (C) Western blot analysis of the indicated proteins to show 
efficiency of the treatments used in panel B. ACTB was used as a loading control. (D) Quantitative real-time PCR to analyze the efficiency of siATP6V0C. (E) U2OS cells 
were depleted for BORC-associated proteins PLEKHM2 (siPLEKMH2) or ARL8B (siARL8B) using silencing RNA for 48 h. Error bars represent S.D. of n > 3 experiments. (F) 
U2OS cells were transfected with KIF5B silencing RNA and/or with KIF5A-GFP overexpression plasmid. Error bars represent S.D. of n > 3 experiments. (G) U2OS cells 
were depleted for KIF5B or PLEKHM2 and the next day treated or not with ConcA for 24 h. Error bars represent S.D of n > 3 experiments. In panels A-B, and 
D-G nuclei were stained with DAPI for detection and quantification of toroidal nuclei compared to total number of cells. * represents the statistical significance of 
single treatment effect compared to control, while # represents the effects of the second treatment over control. * p < 0.05, ** p < 0.005, *** p < 0.001, ns: non- 
significant, # p < 0.05 and ## p < 0.005, ### p < 0.001.
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Identification of novel lysosome substrates specifically 
during cell division
Based on the characterization of a remarkable role for lyso-
somes and autophagic vesicles in mitotic progression, we next 
aimed to identify novel substrates of the autophagic-lysosomal 
pathway specifically in mitosis by mass spectrometry analysis. 
Following synchronization of cells at G2, cells were released in 
control media or in media containing ConcA for 7 h. G1- 
enriched cell fractions were processed for mass spectrometry 
analysis. Drug efficacy was validated by LC3 and SQSTM1 
accumulation in the three experimental replicates after ConcA 
treatment (Fig. S6A). Proteomic data analysis identified a total 
of 1749 peptides present in both ConcA and control fractions, 
while only 13 and 141 were uniquely detected in control and 
ConcA fractions, respectively (Figure 6A). Enrichment analy-
sis validated 853 peptides being differently expressed 
(q-value<0.05) that were selected based on ± 1.2-fold change 
cut-off (Figure 6B). In accordance with its role in inhibiting 
lysosome-dependent degradation, ConcA significantly 
induced protein accumulation. The list of candidates was 
clustered into cellular functions using Reactome opensource 
database [43,44]. Reactome analysis highlighted that proteins 
accumulated after lysosome inhibition specifically during 
mitosis were mainly involved in cell cycle, vesicle-mediated 
transport or DNA repair (Fig. S6B and Table S1). As expected, 
SQSTM1 was significantly increased by 2.73-fold in the 
ConcA fraction compared to control (Figure 6B). Next, we 
focused on those candidates that clustered in functional anno-
tations related to mitosis and cell cycle regulation based on 
gene ontology (GO) enrichment analysis (Table 1). A list of 20 
proteins involved in mitotic cell cycle progress (GO: 1903047) 
were further studied to define the involvement of lysosomes 
in chromosome segregation (Table 1). Interestingly, among 
the principal enriched proteins, the two cofactors of the cohe-
sin complex PDS5B (PDS5 cohesin associated factor B) and 
WAPL (WAPL cohesion release factor) were significantly 
increased by 4.78- and 1.64-fold, respectively (Figure 6B and 
Table 1). To validate the proteomic data, we isolated mitotic 
cells by shake-off after synchronization-release and evaluated 
protein levels in control and ConcA-treated cells. As expected, 
SQSTM1 and LC3-II autophagic proteins accumulated in 
ConcA-treated mitotic fraction (Figure 6C, 6D and S6C). 
Significant increase of both WAPL and PDS5B proteins 
occurred in mitotic cells upon acute impairment of lysosomal 
acidification capacity (Figure 6C and 6D), indicating that both 
PDS5B and WAPL are novel putative lysosomal substrates 
specifically during mitotic progression. To validate our find-
ings in another cell line as well as in a model of autophagy 
impairment, we obtained shake-off fractions from MEF WT 
and atg5-/-. Mitotic fractions of non-synchronized MEF cor-
roborated that PDS5B and WAPL significantly accumulated 
in MEF atg5-/- cells compared to MEF WT (Figure 6E, 6F and 
S6D). Thus, WAPL and PDS5B are potential lysosomal sub-
strates degraded through the macroautophagy machinery.
Figure 5. Defective macroautophagy increases the occurrence of mitotic errors and toroidal nucleus formation. (A) U2OS cells were depleted for ATG5 for 48 h and 
treated or not with ConcA for 24 h. Error bars represent S.D. of n > 3 experiments. (B-C) Quantification of mitotic errors, including chromosome misalignment (B) and 
chromosome bridges (C) in U2OS cells control (siNT) or depleted for ATG5 (siATG5) for 48 h under normal growing condition (CTRL) or treated with ConcA 10 nM 
(24 h). Error bars represent S.D. of n = 4 experiments (>300 cells). (D) Validation of ATG5 depletion and ConcA efficacy in MEF WT and atg5-/- by western blot. ACTB 
was used as loading control. (E) MEF WT and atg5-/- were subjected or not to ConcA treatment for 24 h. DNA was labeled with DAPI and frequency of toroidal nuclei 
was quantified. Error bars represent S.D. of n = 3 experiments. (F) Representative image of normal and toroidal nucleus (yellow arrow) in MEF atg5-/- cells. Scale bar: 
5 µm. (G-H) Quantification of mitotic errors, including chromosome misalignment (G) and chromosome bridges (H), respectively, in WT and atg5-/- MEF. Error bars 
represent S.D. of n = 5 experiments (>100 cells). Panels A-C, E and G-H, * represents the statistical significance of ConcA inhibitory effect compared to control, while 
# represents the effects of atg5 genetic depletion. * p < 0.05, ** p < 0.005, *** p < 0.001, ns: non-significant, # p < 0.05 and ## p < 0.005.
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To determine by which mechanism WAPL and PDS5B 
could be recruited and sent to degradation, U2OS cells were 
transfected with exogenous WAPL-GFP plasmid and treated 
or not with ConcA for 3 h after synchronization. Mitosis- 
enriched fractions were then subjected to GFP- 
immunoprecipitation. First, we validated the binding between 
WAPL and its well-described partner PDS5B [45] (Figure 
6G). WAPL-GFP similarly interacted with PDS5B in control 
or ConcA-treated cells, suggesting that their interaction is 
maintained upon lysosomal inhibition. Interestingly, WAPL- 
GFP pulled down with the autophagic receptor protein 
SQSTM1 and this interaction significantly increased upon 
ConcA-treatment (Figure 6G). Interaction between SQSTM1 
and WAPL and PDS5B was also supported by immunofluor-
escence analysis of the endogenous proteins in mitotic cells. 
Interestingly, bright foci containing SQSTM1 highly coloca-
lized with both PDS5B and WAPL in dividing cells (Figure 
6H and 6I). Furthermore, the number of colocalizing puncta 
was significantly increased upon ConcA treatment, support-
ing that WAPL and PDS5B are degraded by the lysosomes 
during mitosis, potentially through SQSTM1-mediated tar-
geted degradation.
In all, our results shed light on a novel regulatory mechan-
ism for accurate mitotic progression, depicting lysosomes as 
key players for correct chromosomal congression and faithful 
genetic transmission (Figure 7). In addition, we identified the 
toroidal nuclei as a read-out of mitotic defects in interphase 
cells, and as such, as a novel biomarker of genotoxicity for 
cancer research.
Discussion
Faithful mitotic progression relies on autophagy and 
lysosomes
During mitosis, dramatic cellular rearrangement occurs to 
support proper chromosome segregation and productive par-
titioning of intracellular organelles. Many membranous com-
partments undergo massive spatiotemporal disruption [16] 
and scheduled protein degradation is required. While the 
role of UPS has been extensively studied, the implication of 
lysosomes and autophagy in cell division still remains elusive 
[17,22,23]. Although lysosome studies are mainly focused on 
interphase cells, endocytic vesicles (including lysosomes) were 
proposed to serve as a membrane source for plasma mem-
brane extension and retraction during mitotic transition 
[14,15]. Recently, PCM1-driven selective degradation of cen-
triolar satellites was shown to maintain centrosome function 
for correct mitotic progression [25], and lysosome leakage was 
proposed to allow correct chromosome segregation [46]. 
Here, our results agree with the persistence of a robust autop-
hagic flux and lysosomal-dependent degradation during mito-
sis [23].
Other publications demonstrated that initiation of autop-
hagy is inhibited during mitosis, even under MTORC1 inac-
tive state, due to CDK1-dependent phosphorylation of ULK1 
[20], or due to WIPI2 degradation [19]. Our results clearly 
demonstrated that autophagosomes and lysosomes are acid-
ified during mitotic progression. From the apparent 
contradiction of these results arises the concept that, while 
de novo autophagosome formation may be inhibited in mito-
sis, preexisting or precursor autophagic vesicles can still play 
a role in mitotic progression. The finding that under basal 
conditions MEF atg5-/- harbor a higher population of toroidal 
nuclei corroborates that autophagy is active and necessary for 
mitosis also in non-transformed cells. Interestingly, even in 
a context of macroautophagy impairment, such as in the case 
of ATG5 depletion, v-ATPase inhibition by ConcA treatment 
tends to increase the occurrence of mitotic errors and toroidal 
nucleus suggesting that other types of autophagy, such as 
microautophagy or chaperone-mediated autophagy (CMA), 
could also be active during mitosis to degrade other protein 
substrates. Among the identified lysosomal substrates in mito-
sis, SQSTM1, an autophagic receptor protein for ubiquiti-
nated cargos, confirms an active macroautophagic flux and 
suggests a potential alternative route to the proteasome for the 
degradation of mitotic factors [47,48].
To note, PCM1 was not detected in our proteomic analysis 
of mitotic cells, supporting that various selective autophagy 
processes might coexist and be timely regulated during mito-
tic progression. Recently, SQSTM1 emerged as a potential 
pivotal player in the crosstalk between UPS and selective 
autophagosome-lysosome degradation [49,50]. Based on 
SQSTM1 bifunctionality and ubiquitin-lysine linkages diver-
sity, we speculate that a potential interconnection between the 
two main degradative pathways exists to correctly distribute 
genetic material.
Control of sister chromatid cohesion during cell division is 
crucial for equal distribution of genetic material. The canoni-
cal evolutionary conserved cohesin complex is one of the 
main molecular entities involved in this process and consists 
of four subunits (SMC1, SMC3, RAD21 and STAG1/3) [51]. 
Currently, most research focuses on cohesin loading processes 
during replication and cohesin-dependent extrusion of chro-
matin loops for DNA-damage repair [52]. In mitosis, cohesin 
supports both mitotic entry and metaphase-to-anaphase tran-
sition. In prophase, cohesin complexes dissociate to allow 
chromatid condensation and separation. At that precise 
moment, cohesin complex disruption is triggered by WAPL 
and PDS5B along the chromatids arms [53,54]. WAPL- 
dependent dissociation at the centromeric region is inhibited 
by SGO (shugoshin) to prevent premature chromatin separa-
tion [55,56]. During metaphase-to-anaphase transition, chro-
mosome dissociation at the centromeric region is regulated by 
APC/C-dependent PTTG1 (PTTG1 regulator of sister chro-
matid separation, securin) ubiquitination, leading to ESPL1 
(extra spindle pole bodies like 1, separase) activation that 
cleaves RAD21 to culminate chromatid separation [57].
Since lysosomes can degrade most biological material and, 
considering that in this study we identified more than 100 
potential lysosomal protein substrates in mitotic cells, we 
favor the idea that the implication of lysosomes in cell divi-
sion is a multifactorial process. Our finding that WAPL and 
PDS5B accumulate upon blockade of lysosomal acidification 
identifies them as potential lysosomal substrates specifically 
during mitosis. Our study reports for the first time the invol-
vement of autophagy- and lysosomal-dependent degradation 
of cohesin cofactors. The identification of WAPL as a novel 








Figure 6. Identification of novel mitotic lysosomal substrates. (A) Venn diagram representing proteins detected by mass spectrometry of synchronized U2OS cells 
released in growing media (CTRL) or ConcA-containing media. (B) Volcano plot depicting fold-changes (FC) (log2) in protein abundances in cells treated with 10 nM 
ConcA. Three independent experiments were analyzed per condition. Dots denote the 1749 unique proteins detected in pre-filtered samples. Threshold at q-value < 
0.05 depicts peptides significantly modified under experimental conditions. Blue dots represent peptides with FC < 0.8. Orange dots correspond to peptides 
presenting a FC > 1.2. Within these candidates, red dots indicate target proteins WAPL, SQSTM1 and PDS5B. (C) Western blot of synchronized U2OS mitotic cell 
fractions after mitotic cell enrichment by shake-off. Indicated proteins were analyzed. ACTB was used as loading control. (D) Quantification of WAPL, PDS5B, SQSTM1 
and LC3-II band intensity in experimental conditions of panel D and normalized to ACTB protein level. Error bars represent S.D. of n = 3 experiments. (E) MEF WT and 
atg5-/- under normal growing conditions were subjected to shake-off. Mitotic enriched cell fractions were then analyzed by western blot and accumulation of WAPL 
and PDS5B was detected in MEF atg5-/-. ACTB was used as loading control. (F) Quantification of WAPL and PDS5B protein levels from panel F normalized to ACTB 
loading control. Error bars represent S.D. of n = 3 experiments. (G) Immunoprecipitation of exogenous WAPL-GFP in U2OS cells treated or not with 10 nM ConcA for 
24 h. Cells only expressing exogenous GFP tag were used as negative control (H-I) Representative images of U2OS treated with ConcA (10 nM) for 24 h. Detection 
and localization of endogenous WAPL (H) or PDS5B (I) together with SQSTM1 were analyzed by immunofluorescence. Nuclei were stained with DAPI (blue). Scale 
bars: 10 µm. Magnification of SQSTM1-positive foci shows colocalization of WAPL with SQSTM1 (H) or PDS5B with SQSTM1 (I). Quantification of SQSTM1-containing 
foci colocalizing with WAPL (H, right panel) or PDS5B (I, right panel) in control and ConcA-treated cells for n ≥ 7 cells. In panels D, F, H-I, statistical significance is 
represented as: * p < 0.05, ** p < 0.005, *** p < 0.001, ns: non-significant.
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SQSTM1 interactor supports the model of selective degrada-
tion of WAPL and PDS5B by the lysosome during mitotic 
transition. However, additional studies are needed to better 
understand the interconnection between lysosome-dependent 
degradation and the regulation of chromatid cohesion during 
mitotic progression, as well as the precise mechanism by 
which WAPL is recognized by SQSTM1 during cell division, 
either through its ubiquitination or indirectly via other 
SQSTM1-interactors. Our findings are specially relevant in 
the context of cancer, as variations in PDS5B and WAPL 
expression correlate cohesin and chromosomal segregation 
defects with aneuploidy and cancer progression [53,58–61].
Toroidal nucleus, a new tool for genotoxicity screenings
The study of mitosis is challenging due to the velocity and 
architectural changes accompanying cell division. To escape 
these obstacles, most mitosis-focused studies take advantage 
of synchronization protocols. However, drugs used for cell 
synchronization, such as nocodazole, do not specifically target 
mitosis but rather essential cellular components like micro-
tubules, thus altering organelles trafficking among other basic 
cellular functions. Currently, the only marker of defective 
mitosis detectable in non-mitotic cells is the micronucleus. 
Although micronuclei are a consequence of chromosome 
missegregation [62], they can be reabsorbed during subse-
quent cell divisions or destroyed by autophagy [63,64]. 
Therefore, complementary read-outs in interphase cells are 
needed for the analysis of mitosis impairment. Here, we show 
that toroidal nuclei form upon inexact mitosis and linearly 
correlate with the occurrence of mitotic errors.
Inhibition of farnesylation was previously proposed to 
drive the formation of donut-shaped nuclei by affecting cen-
trosome function [31]. Here, we demonstrate that toroidal 
nuclei do not uniquely form upon inhibition of protein far-
nesylation. Indeed, FTI did not increase toroidal nucleus 
population in U2OS, while mitotic stressors, such as inhibi-
tion of lysosomal function or monastrol treatment, 
systematically increased the frequency of toroidal nuclei in 
various cell lines. In addition, our results reveal that toroidal 
nuclei form prior to the reformation of the nuclear envelope, 
as it was also described for micronucleus [65].
The fate of micronuclei is still uncertain and four possibi-
lities are under examination: degradation, reincorporation 
into the nucleus, extrusion or persistence in the cytoplasm 
leading to apoptosis or chromothripsis [66]. We expect simi-
larities for toroidal nuclei, but further studies are needed to 
decipher how cells cope with toroidal nuclei. We detected 
toroidal nuclei in several transformed and non-transformed 
cells, designating the presence of this structure as a conserved 
phenotype within most cell lines. However, the occurrence of 
toroidal nuclei likely depends on cell type specificities and/or 
genetic background. Variability in toroidal nucleus frequency 
might also correlate with basal autophagy levels, which are 
known to be cell-type-specific [67]. In conclusion, the detec-
tion of toroidal nuclei is a new tool for the study of impaired 
mitosis in genotoxicity screenings.
Until now, the orchestrated degradation of mitotic factors 
has been mostly attributed to the UPS. Our data reveals an 
additional route in which active autophagy and lysosomes 
promote faithful genetic transmission. Given the promising 
results of lysosomotropic drugs for cancer treatment, our 
study opens an alternative line of research focusing on lyso-
somes modulation to exploit CIN for cancer therapy.
Materials and methods
Cell culture
U2OS, HeLa, A549, HCT116, RKO, LoVo, MCF7, BJ5ta, HFF 
and HEK293-T cell lines were obtained from American Type 
Culture Collection (HTB-96; CCL-2; CCL-185; CCL-247; 
CRL-2577; CCL-229; HTB-22; CRL-4001, SCRC-1041 and 
CRL-11268, respectively). Huh7 cells were purchased at 
JCRN Cell Bank (JCRB0403). MEF WT and atg5-/- were 
kindly provided by Dr. Boya (CIB, Spain). U2OS H2B-GFP 
cell line was kindly provided by Dr. Agell (University of 
Table 1. Table summarizing the 20 candidates identified by mass spectrometry that are clustered in the Gene Ontology (GO) group of mitotic cell cycle progress (GO: 
1903047).
Protein IDs Protein names Gene names Fold- increase
Q00534 Cyclin-dependent kinase 6 CDK6 7.857
Q9NTI5 Sister chromatid cohesion protein PDS5 homolog B PDS5B 4.780
Q15018 BRISC complex subunit Abro1 FAM175B 2.090
O00233 26 S proteasome non-ATPase regulatory subunit 9 PSMD9 1.911
P28070 Proteasome subunit beta type-4 PSMB4 1.831
Q7Z5K2 Wings apart-like protein homolog WAPL 1.645
P50570 Dynamin-2 DNM2 1.644
P19784 Casein kinase II subunit alpha CSNK2A2 1.547
P78406 mRNA export factor RAE1 1.457
P62979 Ubiquitin-40S ribosomal protein S27a; Ubiquitin 40S ribosomal protein S27a RPS27A 1.450
O43823 A-kinase anchor protein 8 AKAP8 1.408
Q08209 Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform PPP3CA 1.372
P18858 DNA ligase 1 LIG1 1.333
P83731 60S ribosomal protein L24 RPL24 1.321
Q9Y2Z0 Suppressor of G2 allele of SKP1 homolog SUGT1 1.307
Q8NFH3 Nucleoporin Nup43 NUP43 1.297
P06730 Eukaryotic translation initiation factor 4E EIF4E 1.264
Q99661 Kinesin-like protein KIF2C KIF2C 1.233
Q13409 Cytoplasmic dynein 1 intermediate chain 2 DYNC1I2 1.225
O14818 Proteasome subunit alpha type-7 PSMA7 1.224
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Barcelona, Spain). SF-8628 were purchased from Millipore 
Sigma (SCC127 M). MC-PED17 cells were a gift from 
Dr. Daniels (Mayo Clinic, Rochester, MN, USA). SU-DIPG- 
XVII cells were a gift from Dr. Monje (Stanford University, 
Stanford, CA, USA). U2OS mCherry-LMNA and U2OS H2B- 
GFP LAMP1-RFP were generated in our laboratory by tran-
sient transfection of plasmids purchased in Addgene reposi-
tory, LAMP1-GFP (34831; deposited by Esteban 
Dell’Angelica), LAMP1-mRFP-Flag (34611; deposited by 
David Sabatini) and mCherry-LMNA (55068; deposited by 
Michael Davidson). U2OS cell line stably expressing Tandem- 
LC3 reporter was also generated in our laboratory after tran-
sient transfection and further selection of plasmid shared by 
Dr. Boya. WAPL-GFP plasmid was kindly shared by 
Dr. Wang (Zhejiang University, China). Briefly, DNA trans-
fection was performed following manufacturer’s instructions 
using Lipofectamine 2000 (Thermo Fisher Scientific, 
11668019) in 1:5 opti-MEM:DMEM medium (Gibco, 
31985070 and 41966052). Cells were selected using 
a fluorescence-activated cell sorter (MoFlo Atrios SORTER). 
Cells were grown in DMEM high glucose (Gibco, 41966052) 
(4 mM L-glutamine, 4.5 g/L glucose, 1 mM pyruvate) 
supplemented with 10% heat-inactivated fetal bovine serum 
(FBS; Thermo Fisher Scientific, A3382001). Cells were incu-
bated at 37ºC, 5% CO2 and 90–95% of relative humidity. 
Specific experimental conditions are indicated in figure 
legends. All chemicals used in this study are reported in 
Table 2.
Cell synchronization at G2
Cells were seeded the day before starting the synchronization 
in DMEM medium supplemented with FBS. Thymidine 
(Sigma-Aldrich, T1895) was added at a final concentration 
of 2 mM for 24 h to synchronize cells at late G1. After 
phosphate-buffered saline (PBS; Gibco, 10010056) washing, 
cells were released to S phase by adding complete DMEM 
for 2 h. Finally, RO3306 (CDK1 inhibitor; Sigma-Aldrich, 
SML0569) was added to cell culture medium at a final con-
centration of 9 μM for 12 h to arrest cells at late G2 (Fig. S1C). 
Experiments with synchronized cells were performed by 
releasing cells in complete DMEM with or without the corre-
sponding drugs for the indicated times. For the obtention of 
Figure 7. Impairment of lysosomes in mitotic cells leads to CIN. Lysosomal function is required for the maintenance of correct cell division and faithful transmission of 
genetic material in the two daughter cells. Functional lysosomes degrade essential mitotic factors necessary for appropriate chromosome segregation. However, 
when lysosomes are dysfunctional either by impairment of their trafficking or acidification capacity, mitotic cells are prompt to accumulate mitotic errors, to generate 
progeny with toroidal nuclei and mitosis is delayed. These alterations are key features of CIN.
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shake-off fractions, synchronized cells were subjected to con-
secutive strokes to the dishes to detach specifically the mitotic 
cells while maintaining the integrity of the cell monolayer. See 
Table 2 for reagents specifications.
Silencing RNA transfections
siRNA transfections were performed following manufacturer’s 
instructions in Opti-MEM medium (Gibco, 31985070) using 
Lipofectamine RNA-iMAX (Thermo Fisher Scientific, 
13778150). Unless otherwise indicated, transfections were 
performed for 48 h. siRNA sequences and concentrations 
used in these studies are listed in Table S2.
Cell cycle analysis
Cells were trypsinized, counted and placed on ice. 500,000 cells 
were centrifuged at 800 x g at 4ºC for 5 min and cell pellet was 
washed with ice-cold PBS, fixed with 70% ethanol and placed at 
−20ºC for at least 24 h. Cells were then washed with ice-cold 
FACS buffer (0.1% BSA [Sigma-Aldrich, A2153], 5 mM EDTA 
in PBS) and centrifuged for 5 min at 800 x g at 4ºC. Supernatant 
was discarded and the cell pellet was resuspended in propidium 
iodide (PI) staining solution (PBS, 0.1% NP40 [Sigma-Aldrich, 
74385], 20 µg/mL RNAse A [Invitrogen, 12091039], 40 µg/mL PI 
[Sigma-Aldrich, S7109]). Cell suspension was transferred to 
a 5 mL tube with cell strainer cap (Corning, 352235) and main-
tained at room temperature protected from light for 15 min. 
Samples were acquired using FACS Canto System (BD 
Biosciences, USA) and analyzed with ModFit LT software 
(Verity Software House).
Protein extraction and western blot
Cells were washed twice with ice-cold PBS, scraped and lysed 
on Lysis Buffer (20 mM Tris-HCl, pH 8, 10 mM EDTA, 
150 mM NaCl, 1% Triton X-100 [Sigma-Aldrich, T8787]) 
supplemented with 1:100 protease inhibitor cocktail (Sigma- 
Aldrich, P8340) and 1:100 phosphatase inhibitors cocktails 2 
and 3 (Sigma-Aldrich, P5726 and P0044). Cell lysates were 
centrifuged at 13000 x g for 10 min at 4ºC. Protein concen-
tration was analyzed using Pierce BCA Protein Assay kit 
(Thermo Fisher Scientific, 23225) following manufacturer’s 
instructions. Equal amounts of protein lysates were resus-
pended in Laemmli SDS-sample buffer and incubated at 
95ºC for 5 min. Proteins were separated on SDS-PAGE and 
transferred to PVDF membranes (Millipore, GE10600121). 
Membranes were blocked with 5% nonfat dry milk (BioRad, 
1706404) in Tris-buffered saline containing 0.1% Tween-20 
(Thermo Fisher Scientific, 28352; TBS-T) for 1 h at room 
temperature. Incubation of primary antibodies was performed 
overnight at 4ºC in 5% nonfat dry milk or 3.5% BSA. After 
three washes in TBS-T, membranes were incubated for 1 h at 
room temperature with secondary antibodies (1:5000) diluted 
in 5% nonfat milk. Upon incubation, membranes were 
washed three times with TBS-T and protein detection was 
performed by using enhanced chemiluminescence kit (GE 
Healthcare, GERPN2232). Blots were scanned with iBright 
detection system (Thermo Fisher Scientific, CL1000). All the 
antibodies used in this study are reported with the corre-
sponding working concentrations in Table 3.
Immunoprecipitation
U2OS cells transfected with WAPL-GFP expression vector or 
GFP-empty vector as negative control were washed twice with 
ice-cold PBS and cellular pellets were kept at −80ºC before 
lysis. Cellular pellet was lysed in ice-cold IP-RIPA buffer 
(100 mM Tris-HCl, pH 7.5, 300 mM KCl, 10 mM MgCl2, 
2 mM EGTA, 20% glycerol [Sigma-Aldrich, G5516], 1.6% 
NP40 [Sigma-Aldrich, 74385]) supplemented with protease 
inhibitors (2X), phosphatase inhibitors cocktails (1X), 1 mM 
PMSF (Sigma-Aldrich, 78830) and 1 mM DTT (Roche, 
10708984001). After 5 min incubation on ice, collected sam-
ples were mechanically lysed with cold syringe and centri-
fuged at 13000 x g for 5 min at 4ºC. Soluble fraction was 
subjected to BCA Pierce protein quantification. Proteins 
(1500 µg per sample) were separated for immunoprecipitation 
at 1 μg/μL concentration. For the immunoprecipitation, 30 μL 
of GFP-Trap beads (ChromoTek, gtma-10) were added to 
each lysate and incubated by rotation overnight at 4ºC. 
Immunoprecipitates were washed three times with IP-RIPA 
buffer. Immunoprecipitated proteins were denatured by the 
addition of 2X sample buffer followed by boiling for 10 min, 
resolved by 4%-20% Criterion TGX Gel (BIO-RAD, 
567–1094) electrophoresis and analyzed by immunoblotting. 
20 μg of the total lysate were loaded as input to control.
Quantitative real-time PCR
Total RNA was extracted using TRIzol (Invitrogen, 93289) fol-
lowing manufacturer’s instructions. 1 μg of total RNA was sub-
jected to reverse transcription and resulting cDNA samples were 




Company and Catalog 
Number
BSA From 0.1% to 
3.5%
Sigma-Aldrich, A2153
Concanamycin A 10 nM Santa Cruz Biotechnology, SC- 
20211A
Chloroquine 10 μM Sigma-Aldrich, C6628
E64d 10 μM Enzo Life Sciences, BML-PI107 
-0001
EDTA 5 mM Thermo Fisher Scientific, 
15575020
FBS 10% Thermo Fisher Scientific, 
A3382001
Glycine 10 mM Sigma-Aldrich, G8898
L744832 (FTI) 10 μM MERCK, 422720
Lys-C 1:50 Wako, 4548995075888
Monastrol 100 μM Sigma-Aldrich, M8515
Nocodazole 1 μM Sigma-Aldrich, M1404
NP40 0.1% to 1.6% Sigma-Aldrich, 74385
MG132 10 μM Sigma-Aldrich, M7449
Phosphatase inhibitor 
cocktails
1:100 Sigma-Aldrich, P5726 and 
P0044




RNAase A 20 µg/mL Invitrogen, 12091039




Thymidine 25 μM Sigma-Aldrich, T1895
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used in PCR amplification using LightCycler 96 SYBR Green 
I Master Mix (Roche Molecular Systems). Primers to amplify 
PLEKHM2 (F: 5ʹ-TCTCGCTGTCGGTGAAGAAG-3ʹ R: 5ʹ- 
AGGTCTTGCAGTCCGTACAG-3ʹ), KIF3A (F: 5ʹ-TGGCT 
GCAAAGTCAGAGATGG-3ʹ R: 5ʹ- ATCTGAAGTCGAAGC 
TCCCG −3ʹ) and ATP6V0C (F: 5ʹ-TCTACAAGAGCTT 
CCTCCAGC-3ʹ R: 5ʹ- CACCTCGGCGAAGATGAGAA-3ʹ) 
were used. Gene expression was normalized to the endogenous 
ACTB/β-actin (F: 5ʹ-AATGTGGCCGAGGACTTTGATTGC-3ʹ 
R: 5ʹ-AGGATGGCAAGGGACTTCCTGTAA-3ʹ).
Immunofluorescence
Cells were grown as monolayers on coverslips and subjected 
to the indicated conditions. Cells were fixed with 4% paraf-
ormaldehyde for 10 min at room temperature. After 5 min 
washing with PBS, cells were permeabilized using 0.1% Triton 
X-100 in PBS for 10 min at room temperature. Next, cells 
were blocked with 1% BSA/0.01% Triton X-100 in PBS plus 
10 mM glycine (Sigma-Aldrich, G8898) for 30 min at room 
temperature. Cells were incubated with primary antibodies for 
one hour at room temperature or overnight at 4ºC. Following 
a series of PBS washes, cells were incubated with secondary 
antibodies for 45 min at room temperature. After two washes 
of 5 min with PBS, coverslips were mounted using Vectashield 
Mounting Solution containing DAPI (Vector Laboratories, 
H-1200). All the antibodies used in this study are reported 
with the corresponding working concentrations in Table 3.
Vesicle acidification and detection assays in live cells
U2OS cells were seeded onto glass coverslips and subjected to 
the indicated conditions. Live cells were washed once with 
PBS and Magic Red (Immunochemistry Technologies, 938) 
and LysoSensor (Invitrogen, L7545) were added to cover the 
cell layer following manufacturer’s instructions. Cells were 
incubated for 20 min under experimental conditions at 
room temperature before image acquisition.
U2OS cells stably expressing the reporter construct 
Tandem-LC3 (mRFP-GFP-LC3B) were seeded onto glass cov-
erslips, treated with ConcA (10 nM) or CQ (10 μm) for 24 h 
and then fixed and mounted as previously explained. 
Autophagosomes are detected as yellow-positive vesicles (red 
+ green) while red-only vesicles correspond to acidified 
autophagic vesicles (autolysosomes), as the pH-sensitive GFP 
fluorophore gets quenched in acidified vesicles.
Image acquisition and analysis
For detailed analysis, images acquisition was performed in 
Leica spectral confocal microscope TCS SP5 using a 63x N.A 
1.4 objective and LAS AF software or Carl Zeiss LSM880 
confocal microscope and Zeiss ZEN software (Oberkochen, 
Germany). Fluorophores were excited with Argon 488, DPSS 
561, Diode 640 and Diode 405 lasers. Image analysis was 
performed using FIJI ImageJ software (NIH, USA).
For toroidal nucleus and mitotic errors quantification, images 
were acquired using Nikon Epifluorescence microscope using 
a 40x dry objective. Image analysis was performed using Cell 
counter plugin from FIJI ImageJ software. Pearson’s correlation 
coefficient was calculated based on confocal images using FIJI 
ImageJ plugin Intensity Correlation Analysis. Mitotic lysosomes 
size and number were analyzed with FIJI ImageJ fixing particle 
size from 0.3 μm2 to infinity. The distribution of mitotic lyso-
somes was calculated with FIJI ImageJ plugin Radial Profile 
Angle as previously described [68].
Table 3. List of primary and secondary antibodies used in this study.
Primary antibodies
Antigen Dilution Source Catalog Number
ATG5 WB 1/1000 Abgent AP1812b
ACTB/ß-Actin WB 1/10,000 WB 1/2000 Sigma-Aldrich Cell Signaling Technology A2228 4967
FBL (fibrillarin) IF 1/75 Santa Cruz Biotechnology sc-25397
Histone 3 WB 1/1000 Cell Signaling Technology 9715
LC3 WB 1/1000, IF 1/100 Cell Signaling Technology pm036
LAMP2 (CD107b) IF 1/300 BD Biosciences 555803
LMNA (lamin A/C) WB 1/1000 Cell Signaling Technology 2032 S
LMNB1 (lamin B1) IF 1/100 ON Abcam ab16048
NPC IF 1/100 ON Abcam Ab-24609
NCL (nucleolin) IF 1/100 Santa Cruz Biotechnology sc-13057
SQSTM1 WB 1/1000, IF 1/200 IF 1/100 MBL Progen M162-3 GP62-C
PDS5B WB 1/1000 Bethyl Lab. A300-537A-M
Phalloidin – Rhodamine IF 1/500 Cytoskeleton Phdh1
Phospho-RPS6KB1/p70-S6K1 (Thr389) WB 1/1000 Cell Signaling Technology 9234
Phospho-RPS6/S6 (Ser235/236) WB 1/1000 Cell Signaling Technology 2211
Phospho-Histone 3 (ser10) WB 1/1000 Abcam ab47297
RPS6KB1/p70-S6K1 WB 1/1000 Cell Signaling Technology 9202
RPS6/S6 WB 1/1000 Cell Signaling Technology 2217
TUBA (α-tubulin) IF 1/250 Sigma-Aldrich T6074
UBTF IF 1/100 ON Santa Cruz Biotechnology sc-13125
WAPL WB 1/1000 IF 1/50 Bethyl Lab. Santa Cruz Biotechnology A300-268A-M sc-365189
Secondary antibodies
Antigen Dilution Source Catalog Number
Anti-mouse Ig HRP WB 1/5000 Dako P0260
Anti-rabbit Ig HRP WB 1/5000 Dako P0399
Anti-mouse (goat), IgG (H + L), Alexa Fluor 488 IF 1/400 Invitrogen A11001
Anti-rabbit (goat), IgG, (H + L), Rhodamine Red-X IF 1/400 Invitrogen R6394
Anti-rabbit (goat), IgG (H + L), Alexa Fluor 546 IF 1/400 Thermo Fisher Scientific A11010
Anti-rabbit (donkey), IgG, (H + L), Alexa Fluor 555 IF 1/400 Thermo Fisher Scientific A31572
Anti-guinea pig (goat), IgG (H + L), Alexa Fluor 488 IF 1/400 Abcam ab150185
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3D reconstitution
Stacks of images acquired at optimal settings with Carl Zeiss 
LSM880 confocal microscope were processed with IMARIS 
Software (Bitplane, Zürich, Switzerland) for 3D image recon-
struction and to generate in silico animations and images.
Live-cell time-lapse videos
For mitotic delay analysis, U2OS H2B-GFP cells were grown 
onto glass-bottom 8-well slides (IBIDI, 80827). After indicated 
treatments, medium was replaced by FluoroBrite medium 
(Gibco, A1896702) and live-cell imaging was performed on 
the Leica spectral confocal microscope TCS SP5. Images were 
taken every 6 min and 33 s for a total time of 24 h using the 
63x glycerol objective.
For lysosome trafficking analysis, U2OS cells stably expres-
sing LAMP1-RFP and H2B-GFP were grown onto glass- 
bottom 8-well slides (IBIDI, 80827). After indicated treat-
ments, medium was replaced by FluoroBrite medium 
(Gibco, A1896702) and live-cell imaging was performed on 
Carl Zeiss LSM880 confocal microscope. Images were taken 
every 5 min for a total time of 24 h using the 63x glycerol 
objective.
For toroidal nucleus and nuclear lamina reformation assays, 
U2OS cells stably expressing H2B-GFP and mCherry-LMNA 
were grown onto bottom-glass 8 chambers slides (IBIDI, 
80827). After addition of FluoroBrite with indicated treatments, 
mitotic cell division was analyzed on a Carl Zeiss LSM880 con-
focal microscope. For toroidal nucleus formation, images were 
taken every 93 s for 16 h using the 63x glycerol objective. For 
nuclear envelope reformation experiment, images were taken 
every 5 min for 16 h using the 63x glycerol objective.
Transmission electron microscopy (TEM)
U2OS cells with or without ConcA (10 nM) treatment for 
24 h were fixed with glutaraldehyde 2.5% in sodium cacody-
late trihydrate 0.1 M pH 7.2 for 2 h at 4ºC. After three washes 
with sodium cacodylate trihydrate 0.1 M of 15 min each, 
samples were incubated for 2 h with osmium tetroxide 1% 
in sodium cacodylate trihydrate 0.1 M at room temperature. 
Samples were washed three times for 15 min with sodium 
cacodylate trihydrate 0.1 M. Then, samples were processed 
through dehydration with ethanol 30% to 100% gradually. 
Samples were then embedded into resin epoxy. After sample 
orientation, polymerization occurred at 60ºC for 48 h. 
Samples were cut using ultramicrotome EM UC6 Leica, first 
in semithin of 250 nm and then ultrathin of 70 nm. Image 
acquisition was performed with TEM microscope JEOL JEM- 
1011. Images were analyzed and processed with FIJI ImageJ 
software (NIH, USA).
Mass Spectrometry
Three replicates of treated samples were processed for protein 
extraction in RIPA lysis buffer (Tris-HCl [pH 8; 50 mM], 
NaCl 150 mM, 1% NP-40, 0.5% sodium deoxycholate, 0.1% 
SDS). Protein concentration was determined and 50 μg of 
each sample was digested using a FASP (Filter-Aided Sample 
Preparation) approach. Briefly, proteins were reduced with 
dithiothreitol (10 mM; 60 min, 32ºC) and alkylated with 
iodoacetamide ([Sigma-Aldrich, A3221], 20 mM; 30 min at 
25ºC in the dark). Samples were loaded onto an Amicon Ultra 
filter 10 kDa, 0.5 mL (Millipore, ACS501002) to remove 
interfering agents with 2 rounds of centrifugations/washes 
with 100 mM ammonium bicarbonate buffer (13,600 x g; 
25 min at room temperature). Digestion was carried out in 
two steps: first, samples were digested (1:50 w sample/w 
enzyme) with Lys-C (Wako, 4548995075888) in 6 M urea 
buffer (Sigma-Aldrich, U5378) for 3 h at 35ºC. Then, the 
samples were diluted 10-fold with 100 mM ammonium bicar-
bonate buffer and digested with modified porcine trypsin 
(Promega, V5111) (1:25 w sample/w enzyme) for 16 h at 
37ºC. The resulting peptide mixture was recovered by centri-
fuging the filter and later the filter was washed twice with 
300 μL of 50 mM ammonium bicarbonate and once with 
200 μL of 20% acetonitrile/50 mM ammonium bicarbonate 
(13,600 x g for 25 min at room temperature). All the fractions 
were pooled, and the final peptide mixture was acidified with 
formic acid. Finally, the final volume of the acidified peptide 
solution was reduced on a SpeedVac vacuum system (Thermo 
Fisher Scientific), and the peptide solution was desalinated 
with a C18 spin column (Thermo Fisher Scientific) following 
supplier’s indications.
Samples were analyzed in a Proxeon 1,000 liquid chroma-
tographer coupled to an Orbitrap Fusion Lumos (Thermo 
Fisher Scientific) mass spectrometer. Samples were re- 
suspended in 0.5% formic acid in water, and 2 μL (1 μg/μL) 
were injected for LC-MS/MS analysis. Peptides were trapped 
on an NTCC-360/75-3-123 LC column and separated using 
a C18 reverse-phase LC column-Easy Spray (Thermo Fisher 
Scientific). The gradient used for the elution of the peptides 
was 1% to 35% in 90 min followed by a gradient from 35% to 
85% in 10 min with 250 nL/min flow rate. Eluted peptides 
were subjected to electrospray ionization in an emitter needle 
(PicoTipTM, New Objective, Scientific Instrument Services) 
with an applied voltage of 2,000 V. Peptide masses (m/z 
300–1,700) were analyzed in data-dependent mode where 
a full scan MS was acquired on the Orbitrap with 
a resolution of 60,000 FWHM at 400 m/z. Up to the 10 
most abundant peptides (minimum intensity of 500 counts) 
were selected from each MS scan and then fragmented using 
collision-induced dissociation (CID) in the linear ion trap 
using helium as collision gas with 38% normalized collision 
energy. The scan time settings were full MS at 250 ms and 
MSn at 120 ms. Generated raw data files were collected with 
Thermo Xcalibur (v.2.2) (Thermo Fisher Scientific). 
MaxQuant 1.6.1.0 Software (Department for Proteomics and 
Signal Transduction, Max-Planck Institute for Biochemistry) 
was used to search the raw data obtained in the MS analyses 
against a SwissProt/Uniprot human database with 
Andromeda Search engine (1.5.6.0). A target and decoy data-
base were used to assess the false discovery rate (FDR). 
Trypsin was chosen as enzyme and a maximum of two mis-
cleavages were allowed. Carbamidomethylation (C) was set as 
a fixed modification, whereas oxidation (M) and acetylation 
(N-terminal) were used as variable modifications. Searches 
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were performed using a peptide tolerance of 7 ppm and 
a product ion tolerance of 0.5 Da. Resulting data files were 
filtered for FDR <1%. Statistical analysis was performed in 
Perseus 1.6.2.1 (Department for Proteomics and Signal 
Transduction, Max-Planck Institute for Biochemistry).
Statistical analysis
Data was analyzed by Excel or GraphPad Prism8 software. 
Results are presented as Mean ± S.D., for the indicated (n) 
independent experiments. Experimental data sets were com-
pared by: (i) Two-sampled, two-tailed Student’s t-test for two 
experimental conditions sharing normal distribution and var-
iance (ii) One-way ANOVA test for more than 2 conditions 
sharing normal distribution and variance. Multiple compar-
isons corrected using Bonferroni test (iii) Kruskal-Wallis test 
for more than 2 conditions and data without assuming nor-
mal distribution. Multiple comparisons were corrected using 
Dunn’s test.
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